Increased Usage of PET-CT to Accelerate the Preclinical Brain Imaging Growth: Fact.MR

Advanced features of new age preclinical brain imaging and growing R&D activities by research institutes expected to bolster the growth in the forecast period

Fact.MR, New YORK: Promising collaborations and partnerships by market players to strengthen their product portfolios and expand their geographic presence are expected to surge the preclinical brain imaging market growth through 2021 and beyond, forecasts a pipeline study on the landscape by award winning consulting firm Fact.MR.

According to the study, development of integrated systems that includes multiple functionalities are expected to provide a stimulus for the growth of the market. Due to technological advancements and rising cases of brain cancer has accelerated the demand for position emission tomography (PET) and computed tomography (CT). Hence, the uptake of PET and CT is expected to provide impetus to preclinical brain imaging sales.

Furthermore, the study shows that the rising prevalence for neurodegenerative disorders such as Alzheimer’s disease, Parkinson’s disease is anticipated to fuel the growth of preclinical brain imaging. With the rising cases all across the globe, market players are focusing on product innovation and incorporating technological advancements to generate new proceedings in the upcoming years. Hence, accelerating the market sales.

“Increasing cases of brain cancer and the rising incidences to detect early symptoms of brain tumor, brain disorders and other diseases has proliferated the use of PET-CT preclinical imaging device,” says the Fact.MR analyst.

Request a report sample to gain comprehensive insights at

Key Takeaways

  • Pharmaceutical companies and CRO are expected to be primary end users
  • North America expected to be the lucrative market 
  • Europe to emerge as a potential market backed by the growing R&D activities
  • Emerging leading players and high investments expected to create a lucrative market in Asia Pacific.
  • Position emission tomography (PET) and computed tomography (CT) expected to collectively account for major market share

Prominent Drivers

  • Growing prevalence for brain cancer across the globe to boost the growth
  • Technological advancements and product innovation remain as key focus for market players, enabling the future prospects
  • Increasing R&D activities and government funding for research stimulating market growth

Key Restraints

  • High cost of imaging technique to act as a major restraint, hampering the demand of preclinical brain imaging

Discover more about the Preclinical Brain Imaging market with figures, data tables and the table of contents. You will also find detailed market segmentation on

Competitive Landscape

Toshiba Medical Systems, Hologic, Inc., Carestream Health, Inc. GE Healthcare, Siemens Healthcare, Philips Healthcare and Hitachi Medical Corporation are some of the key players profiled by Fact.MR. According to the study, the market players are focusing on strategies such as product innovation and research & development activities for future growth prospects.

For instance, in 2020, the University of Nottingham partnered with Kent based company Magnetic Shields Limited (MSL) to launch a new spin-out company, Cerca Magnetics Limited (Cerca) to bring the world's most advanced functional brain scanner to market. The Cerca Scanner offered an unprecedented window on brain function to benefit the people suffering with severe neurological illnesses, like epilepsy.

More Insights on the Preclinical Brain Imaging Market

In its latest report, Fact.MR offers unbiased analysis of the global Preclinical Brain Imaging market. The report divulges essential insights on Preclinical Brain Imaging market on the basis of  imaging type (computed tomography, positron emission tomography (PET), magnetic resonance imaging (MRI), single photon emission computed tomography (SPECT)), end-user (pharmaceutical companies, contract research organization, research institutes, and biotech comapnies), and regions (North America, Latin America, Europe, Japan, APEJ, and Middle East and Africa)

Request more information about Report Methodology

Explore Fact.MR’s Coverage on the Healthcare Domain

Holotomographic Imaging Market: A recent study by Fact.MR on the holotomographic imaging market offers an unbiased analysis on the opportunities and challenges for the forecast period. The study analyzes crucial trends that are currently determining market growth. This report explicates on vital dynamics, such as the drivers, restraints, and opportunities for key market players along with key stakeholders and emerging players.

 Veterinary imaging systems Market: Fact.MR has published a new study to elucidate the potential growth parameters of the veterinary imaging systems market. The study has been authored by a team of seasoned analysts who studied various geopolitical, macro and microeconomics, and sociological factors that can influence the growth of the market in order to reach valuable and reliable conclusions.  

 Non-invasive Coronary Imaging Market: Fact.MR’s expansive non-invasive coronary imaging market report sheds light on the prominent dynamics expected to shape future growth. The study explicates on the prominent drivers, opportunities and trends prevailing across key segments in prominent geographies. Also, information regarding prominent manufacturers has been embedded in the report. 

About Fact.MR

Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. We have offices in US and Dublin, whereas our global headquarter is in Dubai. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analyzed. Reach out to us with your goals, and we’ll be an able research partner.    

US Sales Office:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583
Corporate Headquarter:
Unit No: AU-01-H Gold Tower (AU),
Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers,
Dubai, United Arab Emirates
Source: Fact.MR

Back to news